CVE-2026-52866 is a HIGH-severity vulnerability allowing an attacker within BLE communication range to monopolize a device's only available BLE connection slot. This prevents legitimate users or applications from establishing a connection. The vulnerability has a CVSS score of 7.1 and was published on June 19, 2026. Organizations using BLE-enabled devices should assess their exposure and implement mitigat [truncated]
The CVE-2026-50034 vulnerability affects the Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), allowing attackers within BLE communication range to passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values. This vulnerability has a HIGH severity with a CVSS Score of 7.1. Healthcare organizations and individuals using thi [truncated]
